India’s competition regulator has cleared L’Oréal India’s proposed acquisition of Onesto Labs, the corporate entity behind digital-first personal-care platform Innovist, removing a major regulatory condition from one of the most consequential beauty transactions in India this year.
The Competition Commission of India said the proposed combination involves L’Oréal India acquiring 100% of Onesto Labs. That wording is important because L’Oréal’s original June announcement described the transaction as an agreement to acquire a majority stake in Innovist while retaining the founding team as minority shareholders, with a mechanism for L’Oréal to acquire the remaining minority interests later.
The approval therefore moves the deal materially closer to completion, while the final ownership structure and timing should be read from closing disclosures when the transaction formally completes.
What happened
L’Oréal announced on June 18 that it had signed an agreement to acquire a majority stake in Innovist, founded in 2019 by Rohit Chawla, Sifat Khurana and Vimal Bhola. Innovist’s portfolio includes science-led personal-care brands such as Bare Anatomy and Chemist at Play, with products distributed through D2C, ecommerce, quick commerce and offline retail.
At the time, L’Oréal said the founders would remain involved in operating and scaling the company and that Innovist’s brands would join its Consumer Products Division. L’Oréal also said completion was subject to regulatory approvals and customary closing conditions.
On September 22, CCI approved the proposed combination. PTI reporting based on the regulator’s release says the combination covers acquisition of the entire shareholding of Onesto Labs by L’Oréal India. CCI’s detailed order is expected separately.
Why it matters
This transaction is bigger than the acquisition of a few fast-growing brands. It tests whether global beauty groups will increasingly buy Indian consumer insight, local R&D, manufacturing capability and digital distribution infrastructure rather than only introduce international brands into India.
Innovist was built around products designed for Indian consumers and has developed across online-first channels that now shape beauty discovery. L’Oréal brings global research, brand-building, distribution and capital. If the integration works, the combination could create a template for how multinational beauty companies scale locally created Indian brands.
It also raises the strategic value of Indian beauty houses that own formulation capability, manufacturing know-how and brands rather than relying only on outsourced products and paid-media-led growth.
What to watch
The next milestone is formal closing. AdvertisR will watch whether L’Oréal confirms the final shareholding structure, how much operating independence Innovist retains, whether Bare Anatomy and Chemist at Play expand faster offline, and whether L’Oréal uses Innovist’s capabilities to develop additional India-first brands.
The larger question is whether this deal accelerates acquisition interest in other scaled Indian D2C beauty companies with proprietary R&D or manufacturing.
Sources & verification
CCI approval is based on the regulator’s release as reported by PTI/The Economic Times. L’Oréal’s June transaction announcement provides primary deal context. The Economic Times · L’Oréal · L’Oréal Finance.
